{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:08:21Z","timestamp":1790701701051,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer Inc","doi-asserted-by":"publisher","award":["88250917"],"award-info":[{"award-number":["88250917"]}],"id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.lungcan.2026.109337","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:20:53Z","timestamp":1771287653000},"page":"109337","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Patterns of progression in patients with synchronous oligometastatic non-small cell lung cancer after systemic and local radical treatment"],"prefix":"10.1016","volume":"214","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-1493-7282","authenticated-orcid":false,"given":"Valentina","family":"Bartolomeo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4686-9169","authenticated-orcid":false,"given":"Mandy","family":"Jongbloed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9117-6885","authenticated-orcid":false,"given":"Jarno W.J.","family":"Huijs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7159-7869","authenticated-orcid":false,"given":"Andrea Riccardo","family":"Filippi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben E.E.M.","family":"van den Borne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cordula","family":"Pitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hester","family":"Gietema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7611-8824","authenticated-orcid":false,"given":"Juliette","family":"Degens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdolen","family":"Youssef-El Soud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Steens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8723-9801","authenticated-orcid":false,"given":"Safiye","family":"Dursun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5976-0974","authenticated-orcid":false,"given":"Wouter H.","family":"van Geffen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk K.M.","family":"De Ruysscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3521-2535","authenticated-orcid":false,"given":"Lizza E.L.","family":"Hendriks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2026.109337_b0005","unstructured":"Oligometastases. | Journal of Clinical Oncology [Internet]. [cited July 15, 2025]. Available at: https:\/\/ascopubs.org\/doi\/10.1200\/JCO.1995.13.1.8?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed."},{"issue":"122","key":"10.1016\/j.lungcan.2026.109337_b0010","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ejca.2019.09.012","article-title":"EORTC Lung Cancer Group survey on the definition of NSCLC synchronous oligometastatic disease","volume":"1","author":"Levy","year":"2019","journal-title":"Eur. J. Cancer"},{"issue":"12","key":"10.1016\/j.lungcan.2026.109337_b0015","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1016\/j.jtho.2019.07.025","article-title":"Definition of synchronous oligometastatic non\u2013small cell lung cancer\u2014a consensus report","volume":"14","author":"Dingemans","year":"2019","journal-title":"J. Thor. Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2026.109337_b0020","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/S1470-2045(19)30718-1","article-title":"Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation","volume":"21","author":"Guckenberger","year":"2020","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2026.109337_b0025","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s11912-023-01490-6","article-title":"Measured steps: navigating the path of oligoprogressive lung cancer with targeted and immunotherapies","volume":"26","author":"Jongbloed","year":"2024","journal-title":"Curr. Oncol. Rep."},{"issue":"12","key":"10.1016\/j.lungcan.2026.109337_b0030","doi-asserted-by":"crossref","first-page":"4998","DOI":"10.21037\/jtd-22-536","article-title":"Oligoprogression in non-small cell lung cancer: a narrative review","volume":"14","author":"Nguyen","year":"2022","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.lungcan.2026.109337_b0035","doi-asserted-by":"crossref","unstructured":"Ettinger DS, Wood DE, Aisner DL, Akerley W, Bauman JR, Bharat A, et al. Non\u2013Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. May 1, 2022 [cited August 3, 2025]; Available at: https:\/\/jnccn.org\/view\/journals\/jnccn\/20\/5\/article-p497.xml.","DOI":"10.6004\/jnccn.2022.0025"},{"issue":"4","key":"10.1016\/j.lungcan.2026.109337_b0040","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.annonc.2022.12.013","article-title":"Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up\u2606","volume":"34","author":"Hendriks","year":"2023","journal-title":"Ann. Oncol."},{"issue":"4","key":"10.1016\/j.lungcan.2026.109337_b0045","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.annonc.2022.12.009","article-title":"Oncogene-addicted metastatic non-small-cell lung cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up\u2606","volume":"34","author":"Hendriks","year":"2023","journal-title":"Ann. Oncol."},{"issue":"10422","key":"10.1016\/j.lungcan.2026.109337_b0050","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0140-6736(23)01857-3","volume":"403","author":"Tsai","year":"2024","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.lungcan.2026.109337_b0055","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ijrobp.2024.08.031","article-title":"Stereotactic ablative radiation for oligoprogressive cancers: results of the randomized phase 2 STOP trial","volume":"121","author":"Schellenberg","year":"2025","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.lungcan.2026.109337_b0060","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.19.00201","article-title":"Local consolidative therapy Vs. maintenance therapy or observation for patients with oligometastatic non\u2013small-cell lung cancer: long-term results of a multi-institutional, Phase II, randomized study","author":"Gomez","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.lungcan.2026.109337_b0065","article-title":"Impact of immune checkpoint inhibitors and local radical treatment on survival outcomes in synchronous oligometastatic NSCLC","volume":"6","author":"Jongbloed","year":"2025","journal-title":"JTO Clin. Res. Rep."},{"issue":"1","key":"10.1016\/j.lungcan.2026.109337_b0070","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.cllc.2023.09.002","article-title":"Patterns of failure in metastatic NSCLC treated with first line pembrolizumab and use of local therapy in patients with oligoprogression","volume":"25","author":"Friedes","year":"2024","journal-title":"Clin. Lung Cancer"},{"issue":"4","key":"10.1016\/j.lungcan.2026.109337_b0075","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.3390\/cancers12041046","article-title":"Oligoprogressive non-small-cell lung cancer under treatment with PD-(L)1 inhibitors","volume":"12","author":"Rheinheimer","year":"2020","journal-title":"Cancers"},{"issue":"12","key":"10.1016\/j.lungcan.2026.109337_b0080","doi-asserted-by":"crossref","first-page":"4442","DOI":"10.1111\/cas.14605","article-title":"Efficacy of local therapy for oligoprogressive disease after programmed cell death 1 blockade in advanced non-small cell lung cancer","volume":"111","author":"Kagawa","year":"2020","journal-title":"Cancer Sci."},{"key":"10.1016\/j.lungcan.2026.109337_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2023.112947","article-title":"Treatment outcome of patients with synchronous oligometastatic non-small cell lung cancer in the immunotherapy era: Analysis of a real-life intention-to-treat population","volume":"190","author":"Jongbloed","year":"2023","journal-title":"Euro. J. Cancer"},{"key":"10.1016\/j.lungcan.2026.109337_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109769","article-title":"The impact of local control on widespread progression and survival in oligometastasis-directed SBRT: results from a large international database","volume":"186","author":"Cao","year":"2023","journal-title":"Radiother. Oncol."},{"issue":"8","key":"10.1016\/j.lungcan.2026.109337_b0095","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.jtho.2023.05.003","article-title":"Local treatments of oligometastatic and oligoprogressive NSCLC Should become the standard of care","volume":"18","author":"Videtic","year":"2023","journal-title":"J. Thoracic Oncol."},{"key":"10.1016\/j.lungcan.2026.109337_b0100","first-page":"115","article-title":"Stereotactic ablative radiotherapy for oligo-progressive disease refractory to systemic therapy in non-small cell lung cancer: a registry-based phase II randomized trial (SUPPRESS-NSCLC)","volume":"33","author":"Bahig","year":"2022","journal-title":"ctRO."},{"issue":"12","key":"10.1016\/j.lungcan.2026.109337_b0105","article-title":"Prognostic and predictive biomarkers of oligometastatic NSCLC: new insights and clinical applications","volume":"5","author":"Jongbloed","year":"2024","journal-title":"JTO Clin. Res. Rep."},{"key":"10.1016\/j.lungcan.2026.109337_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2025.108722","article-title":"Stratifying risk in oligoprogressive EGFR-mutated non-small cell lung cancer (NSCLC): the role of liquid biopsy","author":"Guijosa","year":"2025","journal-title":"Lung Cancer"},{"issue":"10","key":"10.1016\/j.lungcan.2026.109337_b0115","article-title":"Local ablative therapy followed by osimertinib rechallenge in oligoprogressive, EGFR-Mutated NSCLC: a phase 2 study","volume":"6","author":"Ghafoor","year":"2025","journal-title":"JTO Clin. Res. Rep."},{"issue":"16","key":"10.1016\/j.lungcan.2026.109337_b0120","doi-asserted-by":"crossref","first-page":"8087","DOI":"10.3390\/ijms26168087","article-title":"Cell-Free DNA based next-generation sequencing does not differentiate between oligoprogression and systemic progression in non-small cell lung cancer patients treated with immune checkpoint inhibitors\u2014an explorative study","volume":"26","author":"Rozendal","year":"2025","journal-title":"Int. J. Mol. Sci."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500226000814?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500226000814?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:47:46Z","timestamp":1790700466000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500226000814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":24,"alternative-id":["S0169500226000814"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2026.109337","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patterns of progression in patients with synchronous oligometastatic non-small cell lung cancer after systemic and local radical treatment","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2026.109337","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"109337"}}